marijuana stocks

GW Pharmaceuticals Poised For New All-Time High Close On Appropriate Day

Joel Elconin is the co-host of Benzinga’s #PreMarket Prep, a daily trading idea radio show.

GW Pharmaceuticals (NASDAQ: GWPH) shares were up about $0.31 at $114.31 in Monday’s session. The issue, one of the only bright spots in the marijuana sector this year, is attempting to post an all-time closing high on a very appropriate day, April 20, better known as 4/20 in marijuana culture.

The issue, which leaped in one week from its April 9 close ($90.84) to $114 on April 16, on the heels of positive data regarding its blockbuster drug Epidiolex for the treatment of Epilepsy, has found a group of willing sellers in the $116 handle.

Related Link: Marijuana Stocks Not Very High On 4/20

After peaking on Friday at $116.42, it found sellers ahead of that level in Monday’s session at $116.14, before falling back under its all-time high close of $114.

So far, GW Pharmaceuticals has far outperformed the broad market for 2015, rallying from its December 31 close ($67.68) or 68 percent (based on $114), compared with the broad market’s return of 2 percent.

See more from Benzinga


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

High Tide Inc. (HITI) Opens Second Canna Cabana in Ajax, Ontario

High Tide Opens Second Canna Cabana in Ajax, Ontario High Tide Inc.…

United Cannabis Corporation (CNAB) Names Former Ford Motor Company Exec as Chief Marketing Officer

United Cannabis Names Former Ford Motor Company Exec as Chief Marketing Officer…

Trulieve Cannabis Corp. (TCNNF) Announces Transition of Accounting Leadership

Trulieve Announces Transition of Accounting Leadership Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX:…

$GWPH Announces New Planned Epidiolex Development Program

GW Pharmaceuticals Announces New Planned Epidiolex (Cannabidiol or CBD) Development Program in…